Shares worth over Rs 39,385 crore of Vishal Mega Mart Ltd. and Sai Life Sciences Ltd. are set to exit lock-ins on Tuesday as per Nuvama's report.
As much as 56% equity of Vishal Mega Mart and 48% equity of Sai Life Sciences is becoming eligible for trade.
254.2 crore shares of Vishal Mega Mart worth Rs 31,775 crore will be free to trade, almost four times more than the IPO size.
Vishal Mega Mart debuted strongly, listing at Rs 104 against the IPO price of Rs 78, now trading around Rs 125 with a 60% return.
Sai Life Sciences had a robust post-IPO performance, listing at Rs 764 against the IPO price of Rs 549, currently trading at Rs 763.
Analysts' view on Vishal Mega Mart - seven recommend 'Buy', one 'Hold', one 'Sell', with targets ranging from Rs 90 to Rs 161.
Sai Life Sciences is tracked by four analysts, two 'Buy', one 'Hold', one 'Sell', with the most bullish target at Rs 911 by Morgan Stanley.
Shares worth Rs 31,775 crore of Vishal Mega Mart and Rs 7,610 crore of Sai Life Sciences will become free to trade.
Vishal Mega Mart and Sai Life Sciences have impressive investor confidence and performance post-IPO.
Vishal Mega Mart's equity value post lock-in period is nearly four times the IPO size, while Sai Life Sciences' value is 2.5 times the IPO size.
Vishal Mega Mart stock surged from IPO price of Rs 78 to current Rs 125, representing a 60% return.
Sai Life Sciences' stock listed at Rs 764, currently trading at Rs 763, showing investor confidence.
Analysts foresee positive outlook for both Vishal Mega Mart and Sai Life Sciences stocks with varied target prices.
The news mentions the end of the lock-in period for the shares of Vishal Mega Mart and Sai Life Sciences on Tuesday.
Investor interest remains strong in both companies, with Vishal Mega Mart showing a 60% return over the IPO price and Sai Life Sciences remaining 38% above its issue price.